Abstract

Editorial1 July 1957THE NEWER RESPIRATORY VIRUSESPAUL W. CLOUGH, M.D.PAUL W. CLOUGH, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-47-1-178 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptMinor respiratory infections, although rarely fatal, nevertheless are the commonest cause of disability and loss of time from work. Highly contagious and prone to spread with great rapidity through institutions and closed groups, they have been an urgent problem for the military forces. Although much study and effort have been devoted to them, many of the problems concerned have proved baffling.Although many different agents are obviously concerned in these infections, it has not been possible to classify them on an etiological basis simply by a study of their clinical manifestations. Innumerable cultural studies have uniformly failed to incriminate any...1 Commission on acute respiratory diseases: The transmission of primary atypical pneumonia to human volunteers, Bull. Johns Hopkins Hosp. 79: 97-167, 1946. MedlineGoogle Scholar2 Commission on acute respiratory diseases: Experimental transmission of minor respiratory illness to human volunteers by filter-passing agents. I. Demonstration of two types of illness characterized by long and short incubation periods and different clinical features, J. Clin. Investigation 26: 957-973, 1947. MedlineGoogle Scholar3 Commission on acute respiratory diseases: Experimental transmission of minor respiratory illness to human volunteers by filter-passing agents. II. Immunity on reinoculation with agents from the two types of minor respiratory illness and from primary atypical pneumonia, J. Clin. Investigation 26: 974-982, 1947. CrossrefMedlineGoogle Scholar4 HillemanWerner MRJH: Recovery of a new agent from patients with an acute respiratory illness, Proc. Soc. Exper. Biol. and Med. 85: 183-188, 1954. CrossrefMedlineGoogle Scholar5 Huebner RJ: Adenoidal-pharyngeal-conjunctival agents, New England J. Med. 251: 1077-1086, 1954. CrossrefMedlineGoogle Scholar6 Willeman MR: Biophysical characterization of the RI (RI-67) viruses, Proc. Soc. Exper. Biol. and Med. 89: 587-593, 1955. CrossrefMedlineGoogle Scholar7 Rowe WP: Studies of the adenoidal-pharyngeal-conjunctival group of viruses, Am. J. Hyg. 61: 197-218, 1955. Google Scholar8 Enders JF: "Adenoviruses": group name proposed for new respiratory tract viruses, Science 124: 119, 1956. CrossrefMedlineGoogle Scholar9 Bell JA: Pharyngoconjunctival fever. Epidemiological studies of a recently recognized disease entity, J. A. M. A. 157: 1083-1092, 1955. CrossrefMedlineGoogle Scholar10 Hilleman MR: Outbreak of acute respiratory illness, caused by RI-67 and influenza A viruses, Fort Leonard Wood, 1952-1953, Am. J. Hyg. 61: 163-173, 1955. Google Scholar11 Ginsberg HS: Etiologic relationship of the RI-67 agent to acute respiratory disease (ARD), J. Clin. Investigation 34: 820-831, 1955. CrossrefMedlineGoogle Scholar12 Hilleman MR: Epidemiology of RI (RI-67) group respiratory virus infections in recruit populations, Am. J. Hyg. 62: 29-42, 1955. MedlineGoogle Scholar13 Berge TO: Etiology of acute respiratory disease among service personnel at Fort Ord, California, Am. J. Hyg. 62: 283-294, 1955. MedlineGoogle Scholar14 Bell JA: Efficacy of trivalent adenovirus (APC) vaccine in naval recruits, J. A. M. A. 161: 1521-1524, 1956. CrossrefMedlineGoogle Scholar15 Hilleman HR: Adenovirus (RI-APC-ARD) vaccine for prevention of acute respiratory illness, J. A. M. A. 163: 4-9 and 9-15, 1957. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics 1 July 1957Volume 47, Issue 1Page: 178-184KeywordsArmed forcesDisabilitiesUpper respiratory tract infections Issue Published: 1 July 1957 PDF DownloadLoading ...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call